INJ Defies Gravity at $13 Support—Is a $15 Breakout Imminent?
Injective's INJ token clings to its $13 lifeline—traders are betting the house on a rebound.
Key Support Holds Firm
No fancy footwork here—just a brutal test of the $13 floor. Bulls absorbed every sell order without blinking. Now, the charts whisper about unfinished business near $15.
Liquidity Hunt Underway
Market makers smell blood. A push past $14.50 could trigger algorithmic buy walls—and leave short sellers scrambling to cover. Classic crypto volatility at work.
Macro Winds Shifting?
While traditional finance debates yield curves, INJ's price action scoffs at Fed policy. Decoupling narrative gains steam—until the next CPI print, anyway.
One cynical truth: In crypto, 'key support' just means 'last price before the dump.' But for now, the bulls have the mic.
Injective (INJ) price is currently consolidating near the $13.20 level after a recent pullback from its local highs. The price action shows signs of stabilization, with bulls reclaiming momentum for a potential move toward the $14.80–$15.20 range. However, if the current support fails to hold, a drop back toward the $12.00–$12.30 zone remains likely. Will the INJ price build enough strength to break higher, or is a deeper retracement back to earlier levels on the cards?
The token is trading around the $13 mark, supported by strong fundamental momentum. Institutional staking provider BitGo’s addition to the validator set bolstered network security, instilling confidence during a key correction phase. Before that, Injective’s EVM testnet launch and integrations with Google Cloud and Deutsche Telekom triggered a ~15% rally. This drove increased developer activity and investor interest.
While no major updates have emerged in the last 48 hours, these catalysts continue to anchor INJ’s resilience, setting the stage for a closer look at its current technical setup.
The current price action of Injective shows the token being confined within an ascending triangle. The recent rebound before hitting the ascending support suggests that the bulls hold significant dominance. Moreover, the 50/200-day MAs are about to undergo a bullish crossover along with the MACD, which is showing a drop in the selling pressure. These indicate that the price could maintain an ascending consolidation and reach the resistance threshold between $15.79 and $16.25. Meanwhile, the drop in the inflow of money could raise some concerns.
The Chainkin Money FLOW (CMF) is dipping and has dropped from 0.23 to 0, indicating a drop in the money flow. However, the levels are printing consecutive higher highs and lows, which suggests a rebound could be on the horizon. Therefore, the Injective (INJ) price is believed to maintain a strong ascending trend and enter the crucial resistance zone anytime in the next couple of days. Once the price surpasses the zone, reaching above $20 may not be a tedious job for the INJ price rally.
